ACIP Recommendations: Japanese Encephalitis Vaccine

Key points

  • The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
  • These recommendations become official CDC policy once adopted by CDC's Director.
  • Learn about current and historical ACIP recommendations for Japanese Encephalitis vaccine.

Published in Morbidity and Mortality Weekly Report (MMWR)

Recommendations made by the Advisory Committee on Immunization Practices (ACIP) are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

CURRENT Japanese Encephalitis Vaccine Recommendations

MMWR, July 19, 2019, Vol 68(RR-2);1–33
Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
Print version

See also:
CDC's Traveler's Yellow Book on JE

ARCHIVED Historical Japanese Encephalitis Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

MMWR, November 15, 2013, Vol 62(45);898-900
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the ACIP, 2013
Print version

MMWR
, May 27, 2011, Vol 60(20);661-663
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine
Print version

MMWR
, May 27, 2011, Vol 60(20);664-665
Update on Japanese Encephalitis Vaccine for Children – United States, May 2011
Print version

MMWR
, March 12, 2010, Vol 59(RR-01);1-27
Japanese Encephalitis Vaccines: Recommendations of the ACIP
Print version